Expression of extracellular matrix protein CCN1 is induced in end-stage ischaemic cardiomyopathy in humans, and after cardiac ischaemia and reperfusion in experimental animal models. Despite its well-documented angiogenic activities, CCN1 increases the cytotoxicities of the tumour necrosis factor family cytokines, which promotes apoptosis in fibroblasts. We aimed to determine the physiological function of CCN1 in an injured heart.
Introduction
Extensive research has focused on cardioprotective pharmacotherapy to protect cardiac cells from various stress-related insults. Although many potential cardioprotective agents have been identified and tested in clinical trials, their value in reducing cardiac infarcts remains uncertain. 1 A better understanding of the cellular mechanism underlying myocardial injury is critical for identifying effective therapeutic targets. Fas ligand (FasL) and its receptor Fas (CD95/APO-1), both of which are involved in cell-death regulation, have been implicated 2 -4 as significant factors in various cardiac pathologies, such as myocardial infarction (MI), ischaemia-reperfusion (I-R) injury, and chronic heart failure. Fas (lpr)-deficient mice have a smaller infarct area and less myocyte apoptosis after I-R. 5, 6 Despite the pivotal role of Fas/FasL in cardiac injury, delivering an activating anti-Fas monoclonal antibody (Jo2) in normal mice does not induce cardiomyocyte apoptosis in vivo. 7, 8 Likewise, cardiomyocytes in vitro are resistant to FasL-induced apoptosis. 3, 9 These observations show that one or more additional factors in damaged heart tissue are necessary for Fas-induced apoptosis.
Integrin -matrix interactions often provide cell survival cues and prevent Fas-related apoptosis. 10 However, accumulating evidence has identified a number of extracellular matrix (ECM)-associated signalling proteins involved in stimulating apoptotic cell death, rather than survival. 11 -13 Among these, CCN1/Cyr61 promotes the cytotoxicity of FasL and other tumour necrosis factor (TNF) family † These authors contributed equally to this work.
cytokines. 11 CCN1 promotes cell type-dependent and contextdependent cell adhesion, migration, proliferation, differentiation, and survival or death. 14 CCN1 is dynamically expressed in developing cardiovascular and skeletal systems during embryogenesis, and embryonic Ccn1-null mice die from the cardiovascular defects caused by excessive apoptosis in developing vessels or hearts. 15, 16 In adults, CCN1 expression is largely silenced in most tissue, but is redeployed upon tissue injury and in a variety of pathological conditions. 17, 18 CCN1 has been linked to the enhancement of TNF-related apoptosis and tissue damage in various animal models. 19, 20 Mechanistically, the diverse functions of CCN1 are mediated through a number of cellsurface integrin receptors. For instance, CCN1 promotes endothelial cell survival and angiogenesis via integrin a v b 3 , but promotes fibroblast apoptosis through a 6 b 1 with heparan sulfate proteoglycans (HSPG) as co-receptors. 14, 21 In the heart, CCN1 is induced after MI and in end-stage ischaemic cardiomyopathy in humans, and following I -R in experimental animal models.
18 CCN1 alleviates cardiomyopathy in a murine autoimmune myocarditis model by acting on spleen macrophages and preventing immune cell infiltration to the heart, rather than acting directly on cardiac cells. 22 The exact role of CCN1 in a stressed heart remains unknown. It is of great clinical interest to discern and understand how CCN1 regulates cardiac cell survival during heart injury. We used an isoproterenol (ISO)-induced myocardial injury model to test the function of CCN1 in cardiac injury in mice. ISO, an agonist of b-adrenergic receptors (b-ARs), induces myocardial injury and diastolic dysfunction in mice. 23 In patients with a failing heart, persistent b-AR activation can cause cardiac myocyte death, adverse cardiac remodelling, and fibrosis. 24 ISO induces cardiomyocyte apoptosis by inducing FasL expression. 25 We hypothesized that CCN1 regulates cardiac susceptibility to stress-induced injury by up-regulating Fas signalling. ISO-induced myocardial injury in wild-type (WT) and Ccn1-mutant mice was compared to assess our hypothesis.
Methods

Animals, histology
We generated two knock-in transgenic mouse lines-Ccn1 +/lacZ and Ccn1 dm/dm -on the C57BL/6 background, as previously described. 16, 19 For the myocardial injury model, ISO was delivered to 3-to 6-month-old male mice as previously described 23 (see also 
Culturing neonatal rat ventricular myocytes
Neonatal rat ventricular myocytes (NRVM) were isolated from 1-to 3-day-old Sprague-Dawley rats (euthanized by decapitation) as previously described. 26 Freshly isolated NRVM were cultured for 2 days before all experiments. We routinely obtained .90% myocytes in the primary cultures based on immunostaining with anti-troponin I.
Proteins, reagents, and antibodies
Purified recombinant CCN1 and CCN1-DM proteins were generous gifts from Lester Lau, PhD (University of Illinois at Chicago). Human trimeric FasL was from Axxora. SB202190, N-acetyl cysteine (NAC), gelatin, and general chemicals were from Sigma. T1 peptide was from Angene Biotech (Taiwan). Anti-caspase-3, anti-caspase-8, anti-p38, and antiphospho-p38 were from Cell Signaling. Anti-b-tubulin was from Millipore.
Annexin V/propidium iodide staining for apoptosis
Treated cells were harvested and incubated with FITC-conjugated annexin V antibody (BD Biosciences) and propidium iodide (PI) at room temperature for 15 min before they were analysed with flow cytometry. WinMDI was used to further analyse the results.
Cell attachment assays
Assays for cell attachment were as previously described. 27 The number of attached cells was assessed 8 h after seeding (5 × 10 4 cells/well) on the non-tissue culture 96-well plates coated with CCN1 or CCN1-DM; the cells were stained with crystal violet and A 600 was measured.
Western blotting
Total cell lysates were electrophoresed, transblotted, and immunoblotted following standard procedures with the antibodies indicated in the figure legends. All experiments were done at least three times and yielded a similar pattern.
Reactive oxygen species measurements
For hydrogen peroxide, live cells were loaded with indicator dye CM-H 2-DCFDA (5 mM) for 15 min at 378C, and then treated with CCN1. Subsequently, the cells were harvested and resuspended in cold phosphate buffered saline (PBS) containing 5% foetal bovine serum. Flow cytometry was used to analyse fluorescence.
Surface display of Fas analysis
Cells were harvested and incubated with FITC-conjugated anti-Fas (Santa Cruz) or FITC-normal mouse IgM (Santa Cruz) on ice for 20 min, and then analysed with flow cytometry.
Statistical analysis
All assays were repeated at least three times and yielded similar patterns.
Values are means + SEM. Comparisons were made using one-way (cellbased assays) or two-way (animal study) ANOVA and post hoc tests. Significance was set at P , 0.05 and indicated as: NS, no significant difference; *P , 0.05; **P , 0.01; and ***P , 0.001.
Results
Functional mutation of Ccn1 prevented ISO-induced myocardial injury in vivo
To examine Ccn1 expression during ISO-induced myocardial injury, ISO was delivered to Ccn1 +/lacZ mice in which one allele of Ccn1 CCN1 promotes stress-induced cardiac injury was replaced by a lacZ reporter-encoding sequence. 16 Heart tissue was collected 1 day after the completion of ISO injections, and Ccn1 expression was assessed using X-gal staining to detect LacZ activity, which reflects endogenous Ccn1 promoter activity. In healthy cardiac tissue, LacZ activity is localized to large blood vessels ( Figure 1A , arrowheads) and not detectable in cardiac muscles ( Figure 1A , PBS). Upon ISO-induced injury, Ccn1 expression was markedly induced in the damaged myocardium, particularly in the cardiomyocytes near the injured areas ( Figure 1A , ISO; arrows in inset).
To investigate the role of CCN1 in ISO-induced cardiac injury, we used a Ccn1 dm/dm (DM) mouse line, in which Ccn1 had been replaced with a mutant allele, Ccn1-dm, that encodes an integrin a 6 b 1 / HSPGs-binding defective mutant protein. 19 DM mice exhibit no noticeable cardiovascular or other developmental defects. Hearts were collected from DM mice and WT controls 2 days after the completion of ISO injections. Myocardial damage was readily seen in the tissue samples from WT hearts after the WT mice had been injected with ISO (H&E staining) ( Figure 1B , arrow), and fibrosis in the injured area was evident (trichrome staining) ( Figure 1C , arrow). Cardiomyocyte apoptosis, measured using TUNEL staining (red, or pink when merged with DAPI staining), was higher in the myocardium of ISOtreated WT mice ( Figure 1D ). In addition, the loss of cardiomyocytes was evidenced by a significant reduction of the troponin I + cardiomyocytes ( Figure 1D , green), although the damaged tissue area contains numerous infiltrating cells ( Figure 1C and D, arrows). Remarkably, ISO did not cause noticeable injury, fibrosis, or apoptosis in DM mice ( Figure 1B-D) , which showed that CCN1 is critically involved in the loss of cardiomyocytes through apoptosis in ISO-induced injury. Moreover, a 6 b 1 /HSPGs-binding activity of CCN1 is required for the effect.
CCN1 and FasL synergized to induce cardiomyocyte apoptosis
Because it has been indicated that ISO-induced cardiotoxicity is mediated through the production of FasL and its downstream signalling, 25 we hypothesized that CCN1 synergizes with FasL/Fas to induce apoptosis. First, we examined whether CCN1 and FasL were proximal or even overlapping in cardiac tissue. IHC staining showed that an ISO challenge significantly increased the FasL protein level in the myocardium ( Figure 1E) , with the most intensified staining occurring at the edge of the infarcted area, where apoptosis occurs ( Figure 1E , arrowheads). This pattern of FasL protein distribution is similar to that of CCN1, which shows that both factors are physically close together over apoptotic areas after ISO-induced injury ( Figure 1A) . Although the ISO challenge also increased FasL in DM mice, the level was similar to that observed in the non-infarcted area of the hearts of WT mice. The physical proximity of FasL and CCN1 and apoptosis suggested that these two factors synergize to regulate cardiac cell survival. We tested this hypothesis by treating primary cardiomyocytes (NRVM) with CCN1, FasL, and a combination of both factors. The percentage of apoptosis was assessed using flow cytometry analysis after annexin V/PI double staining. Neither FasL (100 ng/mL) alone nor recombinant CCN1 protein (5 mg/mL) induced significant cardiomyocyte apoptosis, which is consistent with previous reports 3, 9 ( Figure 2A ). The combination of both FasL and CCN1, however, induced significant apoptosis after 5 h of incubation (Figure 2A) . Consistent with FasL-induced apoptotic death, the activation of caspase-3 and CCN1 promotes stress-induced cardiac injury caspase-8, judged by the appearance of proteolytically cleaved enzymes, was significantly higher in CCN1+FasL-treated cells, but cells treated with CCN1 or FasL alone showed either no or only mild effects ( Figure 2B-D) .
3.3 CCN1 synergized with FasL through integrin a 6 b 1
As an ECM-associated signalling molecule, CCN1 supports adhesion of many cell types through binding to a variety of integrin receptors.
14 Here, as expected, cardiomyocytes dose-dependently adhered to surface-coated CCN1 protein, with 5 mg/mL of CCN1 approaching maximum effect ( Figure 3A) . Interestingly, CCN1-DM, the mutant CCN1 protein that possesses disrupted integrin a 6 b 1 binding sites, did not support cell adhesion ( Figure 3B) . Moreover, cells preincubated with a soluble a 6 b 1 integrin-binding peptide (T1), a 17-residue peptide sequence derived from an a 6 b 1 -binding site in CCN1, 28 completely blocked adhesion to CCN1 ( Figure 3B ). These results show that CCN1 induced cardiomyocyte cell adhesion through integrin a 6 b 1 . We next investigated whether a 6 b 1 integrin is also necessary for regulating apoptosis. The integrin-binding defective CCN1-DM did not synergize with FasL and the T1 peptide blocked CCN1+FasL-induced apoptosis ( Figure 3C and D) , which showed the critical involvement of a 6 b 1 integrin.
CCN1 induced intracellular reactive oxygen species in cardiomyocytes and mediated oxidative injury in cardiac tissue
Elevated reactive oxygen species (ROS) are important in cell death and in tissue damage caused by cardiac work overload. 29 Because ROS are also critically involved in CCN1 and FasL-mediated apoptosis in certain contexts, 20 we investigated whether ROS mediated CCN1/FasL-induced cardiomyocyte apoptosis and cardiac tissue damage. First, we tested whether CCN1 induces ROS in cardiomyocytes. Cells loaded with DCF-DA were stimulated with CCN1, and then the fluorescence was measured using flow cytometry. CCN1 induced a significant ROS elevation, with the first peak of ROS induction occurring at 5 min ( Figure 4A ). The level of ROS dropped to a basal level within 20 min, after which a second phase of ROS induction took place after 1 h and continued until 5 h of treatments had passed ( Figure 4B ). T1 peptide blocked this CCN1-induced elevation of ROS levels ( Figure 4C ), which indicated an essential role of a 6 b 1 integrin. Secondly, ROS are critical for CCN1+FasL-induced apoptosis ( Figure 4D ), because pre-incubating cells with the ROS scavenger NAC effectively blunted apoptosis. Finally, we examined the involvement of CCN1 in oxidative damage in ISO-induced myocardial injury in mice. Heart tissue was immunostained with an anti-8-OHdG antibody, a marker of oxidative DNA damage. 30 About 40% of the cardiomyocytes in ISO-treated WT mice were 8-OHdG-positive ( Figure 4E , arrowheads), which indicated oxidative injury. In contrast, ,10% of the cells in ISO-treated DM mice were 8-OHdG-positive ( Figure 4E ), which indicated a marked reduction in oxidative damage. These results showed that CCN1 induced ROS in cardiomyocytes, which is critical for CCN1+FasL-induced apoptosis, and for oxidative damage in cardiac tissues in response to injury.
CCN1 induced Fas expression in cardiomyocytes
To investigate how CCN1 synergizes with FasL signalling in cardiomyocytes, we measured the levels of cell-surface Fas by first staining live cardiomyocytes with an FITC-conjugated anti-Fas antibody, followed by flow cytometry. CCN1 elevated cell-surface Fas in 30 min and the effect was sustained for at least 3 h ( Figure 5A ). NAC pretreatment completely blocked the effect ( Figure 5B ), which showed that ROS were required. The level of Fas protein in total cell lysates increased by three-fold after 2 h of incubation with CCN1 ( Figure 5C ). IHC staining of cardiac tissue with an anti-Fas antibody showed that ISO stimulation in WT mice significantly increased Fas in the myocardium ( Figure 5D , red staining, arrow). In contrast, Fas levels in DM mice remained unchanged ( Figure 5D ). These results demonstrated that CCN1 is an important regulator of Fas expression in cardiomyocytes.
CCN1 activated p38 mitogen-activated protein kinase, which regulated Fas expression and apoptosis
Mitogen-activated protein kinase (MAPK) p38 has been implicated in the induction of cardiomyocyte apoptosis by I -R and other stimuli. 4, 31 ROS may elevate p38 MAPK activity by inhibiting MAPKspecific protein phosphatases. 32 Because CCN1 induces ROS in cardiomyocytes, we hypothesized that p38 MAPK is involved in CCN1 signalling. p38 phosphorylation was markedly higher in CCN1-treated cells ( Figure 6A ), which showed that CCN1 alone is sufficient to activate p38 and that FasL is unnecessary. ROS are critical for CCN1-induced p38 activation, because NAC pre-treatment blunted p38 phosphorylation ( Figure 6A ). p38-specific inhibitor SB202190 pretreatment completely blocked both the induction of cell apoptosis by CCN1+FasL ( Figure 6B ) and the elevation of cell-surface Fas by CCN1 promotes stress-induced cardiac injury CCN1 ( Figure 6C ). ISO stimulation in WT mice markedly increased p38 phosphorylation in the myocardium, as shown by IHC staining cardiac tissue with an anti-phospho-p38 antibody ( Figure 6D , red staining, arrow). In contrast, the p38 phosphorylation in the myocardium of DM mice was not changed by ISO. These results demonstrated that p38 MAPK is a critical signalling mediator of CCN1, and that it is necessary for cell-surface Fas expression and apoptosis.
Discussion
We found that the ECM-associated signalling protein CCN1 is a novel regulator of cardiomyocyte apoptosis induced by cardiac work overload. Knock-in mice with endogenous Ccn1 replaced with a cDNA encoding an apoptosis-defective mutant CCN1 (CCN1-DM) became remarkably refractory to ISO-induced cardiac injuries. In isolated cardiomyocytes, CCN1 significantly increased cellular Fas expression through a mechanism dependent upon integrin a 6 b 1 -ROS-p38 MAPK, therefore making cells susceptible to FasL-induced apoptosis ( Figure 6E ). These results demonstrate that CCN1 acts by synergizing with Fas/FasL to control cardiomyocyte apoptosis in a stressed heart. In both human patients and experimental animal models, Fas/FasL critically regulates cardiomyocyte apoptosis and mediates cardiac tissue damage upon work overload. 2 -4 However, Fas/FasL alone is not sufficient to induce cardiomyocyte apoptosis; local or systemic factors induced during cardiac injury may also be necessary. In ISOchallenged mice, CCN1 expression in the myocardium becomes markedly elevated, particularly in areas where apoptosis occurs. Because CCN1 binds strongly to heparin and is localized to the cell surface and ECM, it may be a local factor in cardiac tissue that cooperates with FasL to regulate cardiomyocyte apoptosis. In spite of the pro-survival nature of CCN1 during development, 15, 16 we found that although CCN1 by itself is benign to cardiomyocytes, it causes cardiomyocytes to become susceptible to FasL-induced apoptosis. CCN1 promotes diverse and sometimes opposing cellular responses, depending upon the distinct integrin receptors that mediate its effects in different cell types and contexts. 33 We found that CCN1
enabled Fas-related apoptosis in postnatal cardiomyocytes by binding to integrin a 6 b 1 . Interestingly, embryonic cardiomyocytes express primarily the pro-proliferative a 1 and a 5 integrins, whereas adult cardiomyocytes express primarily the a 6 and a 7 integrins. 34 The enrichment of a 6 in more differentiated cardiomyocytes may in turn transform CCN1-signalling from pro-survival during development into apoptotic stimuli. After engaging with surface integrin a 6 b 1 , CCN1 transduces downstream signals via ROS accumulation and p38 MAPK activation to increase the surface display of Fas. Our data are consistent with a report 35 that p38 is essential for regulating Fas expression. It is worth noting that, upon CCN1 stimulation, the cell surface display of Fas reached a plateau within 30 min, whereas the levels of total Fas protein were gradually up-regulated and became intensified after 2 h of treatment. It is likely that the quick elevation of surface Fas levels is achieved by transporting reserved proteins from the Golgi complex. The link between Fas trafficking and p38 activities has not been reported. Nonetheless, p53, a downstream target of p38 kinase activity, 36 facilitates the cell-surface trafficking of Fas, thereby transiently sensitizing cells to Fas-induced apoptosis. 37 CCN1 may hasten the elevation of surface Fas via expedited membrane trafficking, and concurrently induce the production of Fas to sustain the receptor levels for longer periods of cell action. Increased Fas expression appears to be responsible for cardiomyocyte apoptosis after I -R and in chronic heart failure.
5,38
On a controversial note, it has been suggested 39 that CCN1 protects cardiomyocytes from oxidative stress via b 1 integrins, based on the finding that neonatal cardiomyocytes pre-treated with CCN1 for 24 h become resistant to subsequent H 2 O 2 treatment for another 24 h. The major difference is that the present study focused on the co-treatment of CCN1 and FasL, in contrast to the alternative treatments of CCN1 and H 2 O 2 . That cardiomyocytes are protected by CCN1 may be an indirect effect of a unique experimental setting. We, as well as other animal studies, 5, 18 showed co-localized expression of CCN1 and FasL after cardiac injury. The coexistence of CCN1 and FasL in a stressed heart allows two factors to work synergistically to promote cardiac cell death. The detrimental role of CCN1 in cardiac injury was confirmed by our finding that apoptosis-defective mutant Ccn1-dm knock-in mice were resistant to ISO-induced myocardial damage. This proof-of-concept experiment demonstrated that a stressed heart in mice can be effectively protected from damage by disabling the apoptotic function of CCN1. were immunoblotted with anti-p38 and P-p38 antibodies. Where indicated, cells were pre-incubated with the ROS scavenger NAC (N, 5 mM) for 30 min before adding C+F. Protein band intensity was quantified using the ImageJ program, and the ratio of P-p38/p38 (lower panel) is expressed as mean + SEM of triplicate experiments. (B) Cells were incubated with CCN1 (5 mg/mL), FasL (100 ng/mL), or both (C+F), for 5 h and apoptosis was analysed as before. Where indicated, cells were pre-incubated for 1 h with SB202190 (SB, 1 mM). (C) Cells were treated with CCN1 (5 mg/mL) with or without SB202190 (SB, 1 mM) pre-treatment. Cell-surface levels of Fas were assessed using flow cytometry, as previously described. (D) Cardiac ventricular tissues from WT or DM mice with or without ISO treatment (as described in Figure 1 ) were immunostained with anti-phopho-p38 antibody (red). The infarcted area is delineated with dashed yellow lines. Bars: 50 mm. (E) A diagram showing the mechanism by which CCN1 regulates cardiomyocyte apoptosis during stress-induced injury.
CCN1 promotes stress-induced cardiac injury
We tested the pathogenic role of CCN1 in an ISO-induced myocardial injury model. In addition to the heart injury caused by neurohormonal activation from ISO, FasL has also been implicated in other cardiac pathologies, such as MI, I-R, and chronic heart failure. 2 -4 The expression of CCN1 is induced under the same pathological conditions. 18 Therefore, CCN1 may be critical in a wide range of cardiac diseases. These possibilities are currently under investigation. In summary, our findings provide evidence that CCN1 is a novel pathophysiological regulator that renders cardiomyocytes more susceptible to death stimuli in a stressed heart. CCN1 increases cellular susceptibility to Fas-induced apoptosis by increasing the expression of ROS and cell-surface Fas. Blocking the apoptotic function of CCN1 prevents myocardial injury in mice.
